Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study

Acta Oncol. 2023 Dec;62(12):1961-1966. doi: 10.1080/0284186X.2023.2260943. Epub 2023 Nov 25.

Authors

Rebecca Loison¹, Baptiste Abbar², Leonor Drouin¹, Charlotte Bonnet-Bensimon¹, Caroline Cuvier¹, Sylvie Giacchetti¹, Marc Espie¹, Luis Teixeira¹, Victoire De Castelbajac¹

Affiliations

¹ Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France.
² Sorbonne Université, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie, CLIP² Galilée, Paris, France.

PMID: 37750392
DOI: 10.1080/0284186X.2023.2260943

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Breast Neoplasms* / drug therapy
Breast Neoplasms* / pathology
Female
Humans
Neoplasm Metastasis
Retrospective Studies
Thiotepa / therapeutic use
Treatment Outcome
Vinblastine
Vinorelbine

Substances

Vinorelbine
Thiotepa
Vinblastine